BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28382874)

  • 1. Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up.
    Gotfredsen DR; Wils RS; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AAE; Mors O; Nordentoft M
    Psychol Med; 2017 Sep; 47(12):2118-2129. PubMed ID: 28382874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
    Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
    Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
    Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
    Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
    Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.
    Harrow M; Jobe TH; Faull RN
    Psychol Med; 2014 Oct; 44(14):3007-16. PubMed ID: 25066792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases.
    Liu CC; Lin YT; Liu CM; Hsieh MH; Chien YL; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2019 Aug; 13(4):895-901. PubMed ID: 29927087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
    Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
    Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
    Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
    JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Predictors of Ten-Year Course in First-Episode Psychosis.
    Friis S; Melle I; Johannessen JO; Røssberg JI; Barder HE; Evensen JH; Haahr U; Ten Velden Hegelstad W; Joa I; Langeveld J; Larsen TK; Opjordsmoen S; Rund BR; Simonsen E; Vaglum PW; McGlashan TH
    Psychiatr Serv; 2016 Apr; 67(4):438-43. PubMed ID: 26567932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early recovery and employment outcome 13 years after first episode psychosis.
    Strålin P; Skott M; Cullberg J
    Psychiatry Res; 2019 Jan; 271():374-380. PubMed ID: 30529874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis.
    Haukvik UK; Hartberg CB; Nerland S; Jørgensen KN; Lange EH; Simonsen C; Nesvåg R; Dale AM; Andreassen OA; Melle I; Agartz I
    Psychol Med; 2016 Feb; 46(3):589-98. PubMed ID: 26526001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
    Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
    Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When to initiate antipsychotic treatment for psychotic symptoms: At the premorbid phase or first episode of psychosis?
    Zhang T; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Xie B; Li C; Wang J
    Aust N Z J Psychiatry; 2021 Mar; 55(3):314-323. PubMed ID: 33143440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial.
    Bertelsen M; Jeppesen P; Petersen L; Thorup A; Øhlenschlaeger J; le Quach P; Christensen TØ; Krarup G; Jørgensen P; Nordentoft M
    Arch Gen Psychiatry; 2008 Jul; 65(7):762-71. PubMed ID: 18606949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Oculogyric Crisis and Long-Term Outcomes With Second-Generation Antipsychotics in a First-Episode Psychosis Program.
    Gardner DM; Abidi S; Ursuliak Z; Morrison J; Teehan MD; Tibbo PG
    J Clin Psychopharmacol; 2015 Dec; 35(6):715-8. PubMed ID: 26485339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.
    Lambert M; Conus P; Cotton S; Robinson J; McGorry PD; Schimmelmann BG
    J Clin Psychopharmacol; 2010 Oct; 30(5):565-72. PubMed ID: 20814327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features.
    Craig TJ; Grossman S; Bromet EJ; Fochtmann LJ; Carlson GA
    Compr Psychiatry; 2007; 48(6):497-503. PubMed ID: 17954133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia.
    Takeuchi H; Siu C; Remington G; Fervaha G; Zipursky RB; Foussias G; Agid O
    Neuropsychopharmacology; 2019 May; 44(6):1036-1042. PubMed ID: 30514883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
    Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis.
    Gjerde PB; Dieset I; Simonsen C; Hoseth EZ; Iversen T; Lagerberg TV; Lyngstad SH; Mørch RH; Skrede S; Andreassen OA; Melle I; Steen VM
    Schizophr Res; 2018 Jul; 197():253-260. PubMed ID: 29129510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.